Interventional Cardiology

The Myval THV series is non-inferior to SAPIEN and Evolut THV series at 30 days, offering a promising TAVI alternative.

Polymer-free stents match biodegradable-polymer stents in PCI outcomes but pose a higher early thrombosis risk, requiring careful clinical consideration.

Photon-counting CT outperforms conventional imaging for coronary artery disease, reducing invasive procedures and improving accuracy.

New imaging data show TriClip reduces tricuspid regurgitation and reverses cardiac remodeling, sustaining benefits for one year.

Innovative wearable ACG technology shows promise as a non-invasive diagnostic tool for SLT after TAVR.

Higher rates of bacteraemia and infective endocarditis occur after TAVI compared with CAG, suggesting tailored antibiotic prophylaxis.

SEV and BEV valves with CS or GA yield similar TAVR outcomes; CS lowers mortality and SEVs reduce stroke risk.

Study finds Lipoprotein(a) has no significant impact on aortic valve calcification or mortality in TAVR-treated patients.